Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02910713 · ClinicalTrials.gov registry record · NA

Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation

A NA study of Dry Eye Syndromes, sponsored by Allergan.

Completed
Registry status
NA
Development phase
185
Enrollment target
3
Study locations

NCT02910713 is a NA study of Dry Eye Syndromes that has completed, run by Allergan. The registered enrollment target is 185 participants, below the 404-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02910713, a NA study of Dry Eye Syndromes, has completed, sponsored by Allergan.

COMPLETED
Registry status
NA
Development phase
185 participants
Enrollment target
3
Study locations

Study Summary

This study evaluates the safety and effectiveness of the Intranasal Tear Neurostimulator applied intranasally (active) compared with the same device applied extranasally (control) relating to symptoms of dry eye exacerbated by the Controlled Adverse Environment model.

Conditions Studied

Dry Eye Syndromes

Interventions

  • DEVICE Intranasal Tear Neurostimulator

Study Locations (3)

Tennessee

  • Total Eye Care, PA - Memphis
  • Nashville Vision Associates - Nashville

Kentucky

  • Eye Care Institute - Louisville

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2016-09-30
Est. Completion 2016-10-31
Phase NA

Sponsor

Allergan

314 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02910713

The ClinicalTrials.gov registry entry for NCT02910713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 404-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (54% lower). The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye Syndromes appearing as the primary indexed condition, and to 1 intervention - of which Intranasal Tear Neurostimulator is the first listed.

NCT02910713 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Kentucky.

Frequently Asked Questions

What is clinical trial NCT02910713 about?

NCT02910713 is a clinical study titled "Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation". This study evaluates the safety and effectiveness of the Intranasal Tear Neurostimulator applied intranasally (active) compared with the same device applied extranasally (control) relating to symptoms of dry eye exacerbated by the Controlled Adverse Environment model.

What is the current status of trial NCT02910713?

This trial is currently completed. It is a NA study. The enrollment target is 185 participants. The study started on 2016-09-30. Estimated completion is 2016-10-31.

What conditions does trial NCT02910713 study?

This clinical trial studies the following conditions: Dry Eye Syndromes.

What interventions are being tested in trial NCT02910713?

The interventions under investigation include: Intranasal Tear Neurostimulator (DEVICE).

Who is sponsoring clinical trial NCT02910713?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02910713 being conducted?

This trial has 3 study locations across Kentucky, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dry Eye Syndromes

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.